COMPLETE RESPONSE UNDER SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA IS ASSOCIATED TO DEVELOPMENT OF DERMATOLOGY ADVERSE EVENTS

被引：0
|
作者：
Diaz-Gonzalez, A. [1 ]
Rimola, J. [2 ]
Maria, R. [1 ]
Darnell, A. [2 ]
Varela, M. [3 ]
Pons, F. [4 ]
Hernandez-Guerra, M. [5 ]
Delgado, M. [6 ]
Castroagudin, J. F. [7 ]
Matilla, A. [8 ]
Sangro, B. [9 ]
de Lope, C. R. [10 ]
Margarita, S. [11 ]
Gonzalez, C. [12 ]
Huertas, C. [13 ]
Minguez, B. [14 ]
Ayuso, C. [2 ]
Bruix, J. [1 ]
机构：
[1] Hosp Clin Barcelona, Liver Unit, BCLC GRP, Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Radiol, BCLC Grp, Barcelona, Spain
[3] Hosp Univ Cent Asturias, Liver Unit, Oviedo, Spain
[4] Hosp Univ Puerta de Hierro, Digest Dis Dept, Madrid, Spain
[5] Hosp Univ Islas Canarias, Liver Unit, Tenerife, Spain
[6] Hosp Univ La Coruna, Digest Dis Dept, La Coruna, Spain
[7] Hosp Clin Univ Santiago, Digest Dis Dept, Santiago De Compostela, Spain
[8] Hosp Gen Univ Gregorio Maranon, Digest Dis Dept, Madrid, Spain
[9] Clin Univ Navarra, Liver Unit, Dept Internal Med, Pamplona, Spain
[10] Hosp Univ Marques de Valdecilla, IDIVAL, Liver Unit, Digest Dis Dept, Santander, Spain
[11] Germans Trias & Pujol, Digest Dis Dept, Liver Unit, Badalona, Spain
[12] Hosp Gen Univ Valencia, Liver Unit, Digest Dis Dept, Valencia, Spain
[13] Hosp Univ Doctor Josep Trueta, Digest Dis Dept, Girona, Spain
[14] Hosp Univ Vall dHebron, VHIR, Dept Internal Med, Liver Unit, Barcelona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00433-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-038
引用
收藏
页码：S319 / S319
页数：1
相关论文
共 50 条
  • [21] Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma
    Takano, Michitoshi
    Kokudo, Takashi
    Miyazaki, Yoshihiro
    Kageyama, Yumiko
    Takahashi, Amane
    Amikura, Katsumi
    Sakamoto, Hirohiko
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (42) : 9445 - 9450
  • [22] Sorafenib for the treatment of hepatocellular carcinoma
    Woerns, Marcus Alexander
    Galle, Peter Robert
    HEPATIC ONCOLOGY, 2014, 1 (02) : 189 - 204
  • [23] Sorafenib-Related Adverse Events in Predicting the Early Radiologic Responses of Hepatocellular Carcinoma
    Lee, Shou-Wu
    Lee, Teng-Yu
    Yang, Sheng-Shun
    Tong, Chun-Fang
    Yeh, Hong-Zen
    Chang, Chi-Sen
    GASTROENTEROLOGY RESEARCH, 2019, 12 (01) : 16 - 20
  • [24] Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients
    Tovoli, Francesco
    Ielasi, Luca
    Casadei-Gardini, Andrea
    Granito, Alessandro
    Foschi, Francesco Giuseppe
    Rovesti, Giulia
    Negrini, Giulia
    Orsi, Giulia
    Renzulli, Matteo
    Piscaglia, Fabio
    JOURNAL OF HEPATOLOGY, 2019, 71 (06) : 1175 - 1183
  • [25] Relationship Between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated With Sorafenib
    Yamamoto, Kenta
    Kuzuya, Teiji
    Honda, Takashi
    Ito, Takanori
    Ishizu, Yoji
    Nakamura, Masanao
    Miyahara, Ryoji
    Kawashima, Hiroki
    Ishigami, Masatoshi
    Fujishiro, Mitsuhiro
    ANTICANCER RESEARCH, 2020, 40 (02) : 665 - 676
  • [26] DERMATOLOGIC ADVERSE EVENTS WITHIN THE FIRST 60 DAYS OF SORAFENIB TREATMENT ARE ASSOCIATED WITH BETTER OVERALL SURVIVAL (OS) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Reig, M.
    Rodriguez de Lope, C.
    Llarch, N.
    Forner, A.
    Torres, F.
    Rios, J.
    Boix, L.
    Rimola, J.
    Darnell, A.
    Ayuso, C.
    Bruix, J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S113 - S113
  • [27] Pancreatic Insufficiency in Patients Under Sorafenib Treatment for Hepatocellular Carcinoma
    Diaz-Gonzalez, Alvaro
    Belmonte, Ernest
    Sapena, Victor
    Sanduzzi-Zamparelli, Marco
    Darnell, Anna
    Diaz, Alba
    Gomes da Fonseca, Leonardo
    Llarch, Neus
    Iserte, Gemma
    Ayuso, Carmen
    Forner, Alejandro
    Feu, Faust
    Bruix, Jordi
    Rimola, Jordi
    Reig, Maria
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (03) : 263 - 270
  • [28] Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib
    Christina Wich
    Abbas Agaimy
    Deike Strobel
    Thaddaus Till Wissniowski
    Arndt Hartmann
    Matthias Ocker
    World Journal of Gastroenterology, 2010, 16 (28) : 3592 - 3596
  • [29] Metabolomic Response to Sorafenib Treatment in Human Hepatocellular Carcinoma Cells
    Zhou, Shufeng
    Luo, Ruijuan
    FASEB JOURNAL, 2013, 27
  • [30] Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib
    Wich, Christina
    Agaimy, Abbas
    Strobel, Deike
    Wissniowski, Thaddaeus Till
    Hartmann, Arndt
    Ocker, Matthias
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (28) : 3592 - 3596
12345